Galapagos NV

$24.55 0.00%
PNK: GLPGF
Market Cap.: 1.6 B M
P/E: 46.32 x3.3
EPS: 0.53 x 5.9
Earnings Call
No. The last one was 1 week, 2 days ago
Dividend Waiting Time
n.A.
Latest Dividends History
Yield
Payout
Volume Level
μ 0
190 High
Performance Ranks (Intraday)
Belgium:

43rd

out of

146

Healthcare:

339th

out of

792

Biotechnology:

127th

out of

227

About

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of …